FDA puts $1.1M behind digital health tools in clinical trials
Small money, useful direction. In the same year the agency stepped back from regulating wearables, it started paying for evidence about them.
On 20 July 2026 the FDA posted a funding opportunity for sponsors deploying digital health technologies in clinical trials, with a $1.1 million award ceiling, two expected awards and no cost-sharing requirement. Applications closed 20 August 2026.
The facts, in brief
| Posted | 20 July 2026 |
| Award ceiling | $1.1 million |
| Expected awards | Two |
| Cost sharing | None required |
| Applications closed | 20 August 2026 |
Why a small grant is worth reporting
Because of what it's for. Using a wearable as a measurement instrument inside a regulated clinical trial is a much higher bar than selling one — it requires knowing the error characteristics, the failure modes and the drift. Funding that work produces exactly the kind of public evidence that consumer buyers benefit from second-hand, even though the trials aren't about consumers at all.
$1.1 million across two awards will not transform the field. It does signal that the agency wants the measurement question answered even where it has stepped back from the marketing question.
The tension worth naming
In January the FDA said it would not enforce device requirements across a broad class of wellness wearables. In July it started funding research into how well those sensors actually measure things. Those are not contradictory positions — light-touch regulation plus better public evidence is a coherent policy — but they do put more weight on the evidence half of that bargain than $1.1 million can carry.
the award ceiling for putting digital health technologies to work inside clinical trials — where a sensor's error characteristics actually have to be known.FDA funding opportunity, 20 July 2026
Applandica's read
Priya Raghunathan · Co-founder & Head of TestingThis is the announcement I was most pleased to see this year, and it's the smallest. Consumer wearable validation is chronically underfunded, which is why so much of the literature is either tiny or paid for by the device maker — a pattern we keep running into, most recently where a Whoop-sponsored study reported κ 0.49 and an independent one reported κ 0.37.
Publicly funded measurement research is the cleanest fix for that. Two awards won't do it. Two awards a year, for ten years, might.
Frequently asked questions
What is the FDA funding?
Research into the use of digital health technologies — including wearables and sensors — inside clinical trials, with a $1.1 million award ceiling and two expected awards.
Does this affect consumer apps?
Not directly. Indirectly it helps: validation work done for clinical trials produces public evidence about how accurately consumer-grade sensors measure, which is currently scarce and often industry-funded.
Sources
FTC sues Hims & Hers over health data sent to Meta and Snap
The complaint pairs the two failures we log most often — advertising trackers on sensitive health data, and a…
AnalysisFDA steps back from wearables and AI health software
A January guidance shift means many wearables and AI health tools can reach the market without formal device review.…